Track NGL Fine-Chem Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

NGL Fine-Chem Limited NGLFINE.NS · Stock Open NGL Fine-Chem Limited in new tab

3109.30 INR
P/E
39.70
EPS
78.05
Yield
0.06%
Safety Score
52
P/B
5.81
ROE
15.74
Beta
0.63
Loading chart...
Key Metrics
Earnings dateMay 20, 2026
P/E39.70
EPS78.05
Book Value532.95
Price to Book5.81
Debt/Equity32.96
% Insiders72.561%
Growth
Revenue Growth0.57%
Earnings Growth15.40%
Dividend
Dividend Yield0.06%
Annual dividends1.75 INR
Ex-Div. DateAug. 18, 2026
Payout2.25%

DCF Valuation

Tweak assumptions to recompute fair value for NGL Fine-Chem Limited (NGLFINE.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

NGL Fine-Chem Limited Logo NGL Fine-Chem Limited Analysis (NGLFINE.NS)

Is NGL Fine-Chem Limited a good investment? NGL Fine-Chem Limited (NGLFINE.NS) is currently trading at 3109.30 INR.

In terms of valuation, the stock trades at a P/E ratio of 39.70. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: NGL Fine-Chem Limited is expected to release its next earnings report on May 20, 2026.

For income investors, NGL Fine-Chem Limited pays a dividend yield of 0.06%. With a payout ratio of 2%, the dividend appears sustainable.

Investor FAQ

Does NGL Fine-Chem Limited pay a dividend?

Yes, it pays an annual dividend of 1.75 INR (0.06% yield).

What asset class is NGL Fine-Chem Limited?

NGL Fine-Chem Limited is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be May 20, 2026. The company currently has a trailing EPS of 78.05.

Company Profile

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Trades
Dividend Yield
0.06%
Annual Dividends
1.75INR
Next Ex. Div Date
Aug. 18, 2026
Payout Ratio
2.25%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
2026
1.75 INR
Sept. 24, 2026 1.7500
2025
1.75 INR
Aug. 30, 2025 1.7500
2024
1.75 INR
Aug. 30, 2024 1.7500
2023
3.50 INR
Sept. 24, 2023 1.7500
Aug. 18, 2023 1.7500
2022
1.75 INR
July 30, 2022 1.7500
2021
1.75 INR
Sept. 19, 2021 1.7500
2020
1.75 INR
Sept. 13, 2020 1.7500
2019
1.75 INR
Sept. 22, 2019 1.7500
Upcoming Dividends
Name Payment Date Status Amount
NGL Fine-Chem Limited Sep 24, 2026 Upcoming 1.75 INR
NGL Fine-Chem Limited Aug 30, 2025 1.75 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion